MedTrace Logo

Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis

NCT00465699 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-04-25

No results posted yet for this study

Summary

This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme

Conditions

Interventions

DRUG

Topical B12 0.07%

Sponsors & Collaborators

  • Spartanburg Regional Healthcare System

    lead OTHER

Principal Investigators

  • Ronald P Januchowski, D.O. · Spartanburg Regional Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465699 on ClinicalTrials.gov